San ju San Financial Group,Inc. (TYO:7322)
3,420.00
+20.00 (0.59%)
Aug 14, 2025, 3:30 PM JST
Theseus Pharmaceuticals Revenue
San ju San Financial Group,Inc. had revenue of 19.65B JPY in the quarter ending June 30, 2025, with 9.46% growth. This brings the company's revenue in the last twelve months to 71.25B, up 6.75% year-over-year. In the fiscal year ending March 31, 2025, San ju San Financial Group,Inc. had annual revenue of 69.55B with 4.31% growth.
Revenue (ttm)
71.25B
Revenue Growth
+6.75%
P/S Ratio
1.25
Revenue / Employee
29.96M
Employees
2,378
Market Cap
89.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 69.55B | 2.87B | 4.31% |
Mar 31, 2024 | 66.68B | 1.96B | 3.02% |
Mar 31, 2023 | 64.72B | -1.94B | -2.91% |
Mar 31, 2022 | 66.66B | 333.00M | 0.50% |
Mar 31, 2021 | 66.32B | 1.95B | 3.04% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Mitsubishi UFJ Financial Group | 5,440.78B |
Sumitomo Mitsui Financial Group | 3,346.44B |
Tokio Marine Holdings | 8,308.78B |
Mizuho Financial Group | 3,891.11B |
JAPAN POST BANK | 1,744.57B |
MS&AD Insurance Group Holdings | 6,479.68B |
Dai-ichi Life Holdings | 8,946.80B |
Sompo Holdings | 5,423.41B |